November 8-10, 2021 | Virtual Conference

Register Now en English


Scott Tomsky

Associate Vice President, Global Regulatory CMC

Scott D. Tomsky, Associate Vice President, Global Regulatory CMC, Organon has been actively involved in the pharmaceutical industry for more than 20 years.  Scott recently joined Organon, a global healthcare company formed through as spinoff from Merck with a mission to deliver impactful medicines and solutions for a healthier every day.  In his 20+ years in the industry, Scott has held positions in R&D, Quality Control and Regulatory Affairs.  He has gathered experience at Johnson and Johnson, Ranbaxy, Teva and Merck/Organon.  His regulatory experience includes APIs, sterile products, solid and liquid dosage forms, transdermals, inhalation products and drug/device combination products.  Scott was actively involved in AAM and has served on the AAM GDUFA II negotiating and implementation teams, and was also a member of the industry GDUFA III negotiating team.  He holds a B.S. in Biology and a Minor in Chemistry from Trenton State College in NJ and a M.S. in Quality Assurance and Regulatory Affairs from Temple University.

Get Started & Register

Whether you are an AAM member, general attendee, or exhibitor, come meet the leaders and decision-makers who are determining the future of generics and biosimilars.

Register Now

Skip to content